Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult

• Status: Recruiting
• Trial end date: 2022-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if a topical treatment for dry scalp conditions, is safe and effective in clinically improving dry scalp conditions. The investigators will additionally examine individuals experience in using the treatment as well as any changes in the scalp microbiome before and after use studying the treatment , the investigators hope to offer children and adults a new, natural way to improve dry scalp conditions.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
• Collaborator: Feinberg School of Medicine, Northwestern University

Criteria

Inclusion Criteria:

1. Age 1 year (or corrected age of 1 year, for those born prematurely) to 11 years for children (those who turn 12 over the study period will not be enrolled), and 18 and older

2. Diagnosed with a dry scalp condition with and IGA score of 2 of greater by a board-certified Dermatologist, Allergist, or Pediatrician

3. Good general health

4. Participant and/or their parent are able to read, write, and understand study materials in English

Exclusion Criteria:

1. Infants younger than 1 year old and between the ages of 12 and 18 (those who turn 12 over the study period will not be enrolled)

2. Patients diagnosed with other scalp diseases such as psoriasis, tinea capitis, and pediculosis capitis

3. Systemic steroid or oral antibiotic use during the past two months

4. Allergy to any of the preparation components